Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of Asthma

Patent No. EP3034073 (titled "Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of Asthma") was filed by Chiesi Farmaceutici on Apr 16, 2008. The application was issued on Jun 12, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LUPIN HEALTHCARE UKMar 12, 2020DEHNS
GILL JENNINGS & EVERYMar 11, 2020-
TEVA PHARMACEUTICALSMar 4, 2020ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3034073

CHIESI FARMACEUTICI
Application Number
EP16152451A
Filing Date
Apr 16, 2008
Status
Opposition Rejected
Sep 8, 2023
Publication Date
Jun 12, 2019